Trial Profile
Phase 2 Expanded Safety Study of Tenofovir Gel in Pregnancy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2022
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 26 Mar 2012 Planned End Date added to 1 Aug 2015 as reported by ClinicalTrials.gov.
- 16 Dec 2011 New trial record